J&J research vet Mammen a top contender in Biogen's hunt for a new CEO: Stat
After more than a year of tumult spurred by its disastrous Alzheimer’s disease drug launch, Biogen may be closing in on new leadership. | There are rumblings of a leadership sea change at Biogen, which Stat News reports is strongly considering Theravance co-founder and former J&J R&D head Mathai Mammen, M.D., Ph.D., in its hunt for a new CEO.
